Published in J Clin Epidemiol on January 01, 1991
Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk. J Steroid Biochem Mol Biol (2007) 1.25
Circulating sex steroids and breast cancer risk in premenopausal women. Horm Cancer (2010) 1.03
Smoking as a determinant for plasma levels of testosterone, androstenedione, and DHEAs in postmenopausal women. Eur J Epidemiol (2005) 0.86
Circulating sex steroids during pregnancy and maternal risk of non-epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev (2010) 0.82
Some sex hormone profiles are consistent over time in normal menstruating women: implications for sports injury epidemiology. Br J Sports Med (2009) 0.82
Alteration in sexually dimorphic testosterone biotransformation profiles as a biomarker of chemically induced androgen disruption in mice. Environ Health Perspect (1999) 0.81
Estimating the world cancer burden: Globocan 2000. Int J Cancer (2001) 16.92
General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49
Global cancer statistics. CA Cancer J Clin (1999) 8.82
Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer (1999) 8.61
The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA (1997) 6.32
Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer (1993) 6.24
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20
EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. Ann Oncol (2003) 5.78
Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut (2000) 4.02
EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol (2003) 3.88
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol (1997) 3.39
Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer (2005) 3.04
Overweight as an avoidable cause of cancer in Europe. Int J Cancer (2001) 2.88
Light-induced superconductivity in a stripe-ordered cuprate. Science (2011) 2.54
Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia (2011) 2.43
Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr (2002) 2.25
Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer (2011) 2.20
Patterns of lung cancer risk according to type of cigarette smoked. Int J Cancer (1984) 2.07
Variations in survival from breast cancer in Europe by age and country, 1978-1989. EUROCARE Working Group. Eur J Cancer (1998) 2.04
High endogenous estradiol is associated with increased venous distensibility and clinical evidence of varicose veins in menopausal women. J Vasc Surg (2000) 2.03
Consumption of sweet beverages and type 2 diabetes incidence in European adults: results from EPIC-InterAct. Diabetologia (2013) 1.93
Age at menarche in relation to adult height: the EPIC study. Am J Epidemiol (2005) 1.88
Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology (2000) 1.86
Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe. Eur J Cancer (2011) 1.84
TBARS and cardiovascular disease in a population-based sample. J Cardiovasc Risk (2001) 1.81
Triazine herbicides and ovarian epithelial neoplasms. Scand J Work Environ Health (1989) 1.81
Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology. Eur J Cancer (2003) 1.79
Herpes simplex virus genomes in human nervous system tissue analyzed by polymerase chain reaction. Ann Neurol (1994) 1.78
Acquired dyschromatopsia among styrene-exposed workers. J Occup Med (1991) 1.78
Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst (1996) 1.77
Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer (2001) 1.76
Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol Biomarkers Prev (2001) 1.75
Cancer prevalence in European registry areas. Ann Oncol (2002) 1.72
Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand. Trop Med Int Health (2004) 1.70
Cancer of the larynx/hypopharynx, tobacco and alcohol: IARC international case-control study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France). Int J Cancer (1988) 1.69
Serum uric acid and hypertension: the Olivetti heart study. J Hum Hypertens (1994) 1.66
Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res (1988) 1.66
Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol (2004) 1.63
Toward a comparison of survival in American and European cancer patients. Cancer (2000) 1.63
Genetic susceptibility in familial multiple sclerosis not linked to the myelin basic protein gene. Lancet (1993) 1.62
Enhanced photosusceptibility near Tc for the light-induced insulator-to-metal phase transition in vanadium dioxide. Phys Rev Lett (2007) 1.61
Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer. Cochrane Database Syst Rev (2008) 1.58
Correlates of markers of oxidative status in the general population. Am J Epidemiol (2001) 1.56
Lactation history and breast cancer risk. Am J Epidemiol (1997) 1.54
DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis (2005) 1.54
Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects. Oncogene (2012) 1.53
Exposure to breastmilk in infancy and the risk of breast cancer. Epidemiology (1994) 1.53
Modifying risk of developing lung cancer by changing habits of cigarette smoking. Br Med J (Clin Res Ed) (1984) 1.50
Effects of transportation and delay in processing on the stability of nutritional and metabolic biomarkers. Nutr Cancer (2000) 1.49
Relationship of alcohol intake and sex steroid concentrations in blood in pre- and post-menopausal women: the European Prospective Investigation into Cancer and Nutrition. Cancer Causes Control (2006) 1.47
Fruit and vegetable intake and type 2 diabetes: EPIC-InterAct prospective study and meta-analysis. Eur J Clin Nutr (2012) 1.46
At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer (1994) 1.45
Diet in the aetiology of cancer: a review. Eur J Cancer (1994) 1.45
The prognostic role of gender in survival of adult cancer patients. EUROCARE Working Group. Eur J Cancer (1998) 1.45
Environmental exposure to asbestos and risk of pleural mesothelioma: review and meta-analysis. Eur J Epidemiol (2000) 1.44
Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC). Br J Cancer (2005) 1.44
Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study. Nutr Metab Cardiovasc Dis (2009) 1.43
Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol (2013) 1.43
Urinary styrene in the biological monitoring of styrene exposure. Scand J Work Environ Health (1993) 1.43
Detection of nonthermal melting by ultrafast X-ray diffraction. Science (1999) 1.41
Survival of women with breast cancer in Europe: variation with age, year of diagnosis and country. The EUROCARE Working Group. Int J Cancer (1998) 1.41
Lung cancer screening. Chest (1994) 1.40
IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer (2006) 1.39
Mediterranean diet and type 2 diabetes risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study: the InterAct project. Diabetes Care (2011) 1.39
Increased plasma HDL-cholesterol and apo A-I in breast cancer patients undergoing adjuvant tamoxifen therapy. Clin Biochem (2000) 1.39
Plant-based diet, serum fatty acid profile, and free radicals in postmenopausal women: the diet and androgens (DIANA) randomized trial. Int J Biol Markers (2005) 1.38
Mediterranean dietary pattern and cancer risk in the EPIC cohort. Br J Cancer (2011) 1.35
A case-control study of brain gliomas and occupational exposure to chemical carcinogens: the risk to farmers. Am J Epidemiol (1988) 1.35
Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. Br J Cancer (2006) 1.34
Differences in attitudes toward organ donation among African Americans and whites in the United States. J Natl Med Assoc (2001) 1.33
miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer. Cell Death Dis (2012) 1.33
Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut (2005) 1.32
Trends in postoperative radiotherapy delay and the effect on survival in breast cancer patients treated with conservation surgery. Br J Cancer (2004) 1.30
Clocking the melting transition of charge and lattice order in 1T-TaS2 with ultrafast extreme-ultraviolet angle-resolved photoemission spectroscopy. Phys Rev Lett (2011) 1.30
Radiation dose and leukemia risk in patients treated for cancer of the cervix. J Natl Cancer Inst (1987) 1.28
The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study. Diabetologia (2012) 1.28
Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group. Cancer (2000) 1.27